Australia markets closed

Angion Biomedica Corp. (ANGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.2800+0.0400 (+3.23%)
At close: 04:00PM EDT
1.2800 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
28,312
28,312
2,880
1,487
4,029
Cost of revenue
433
433
1,190
640
378
Gross profit
27,879
27,879
1,690
847
3,651
Operating expenses
Research development
48,698
48,698
38,977
29,837
12,602
Selling general and administrative
18,488
18,488
17,986
9,601
5,391
Total operating expenses
67,186
67,186
56,963
39,438
17,993
Operating income or loss
-39,307
-39,307
-55,273
-38,591
-14,342
Total other income/expenses net
-13,419
-13,419
-15,988
-2,332
-5,935
Income before tax
-54,573
-54,573
-80,107
-40,658
-20,025
Income from continuing operations
-54,573
-54,573
-80,107
-40,658
-20,025
Net income
-54,573
-54,573
-80,107
-40,658
-20,025
Net income available to common shareholders
-54,573
-54,573
-80,107
-40,658
-25,005
Basic EPS
-
-
-2.78
-2.65
-1.63
Diluted EPS
-
-
-2.78
-2.65
-1.63
Basic average shares
-
-
28,780
15,364
15,364
Diluted average shares
-
-
28,780
15,364
15,364
EBITDA
-
-38,506
-54,645
-38,095
-14,340